Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Prebiotic activity" is *not* a molecule or receptor but refers to the property by which certain dietary substances—typically non-digestible fibers like inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS), resistant starches, and others—are selectively utilized by beneficial host microorganisms such as Bifidobacteria and Lactobacillus. This selective utilization leads to positive shifts in the gut microbiota composition that confer measurable health benefits on the host. The concept was first introduced scientifically in 1995. While often equated with dietary fiber, only some fibers qualify as true prebiotics under current definitions. The main biological function is modulation of the intestinal microbiome through fermentation processes that produce metabolites like short-chain fatty acids with systemic immunomodulatory and metabolic benefits. Health roles studied include gastrointestinal function improvement, infection reduction, immune support, mineral absorption enhancement (notably calcium), blood sugar regulation, lipid metabolism improvement—and potential roles against osteoporosis and metabolic diseases. Importantly: "Prebiotic activity" does **not refer to a single molecular entity**, protein target/receptor/enzyme/transporter. It cannot be classified within standard molecular families used for therapeutic targets. There is no canonical abbreviation nor interacting drugs/mechanisms/biomarkers typical for druggable targets. The entry should be flagged as incorrect if used where a specific molecule/receptor/protein target is required. Regarding interacting drugs: Prebiotics are not molecular targets for drugs; rather, they are dietary substances that may be co-administered with probiotics or other supplements. Regarding mechanism of action: Prebiotics do not have mechanisms analogous to drug-target interactions. Their "mechanism" is selective utilization by host microorganisms leading to beneficial physiological effects through changes in the microbiome. Regarding biomarkers: There are no established biomarkers for patient selection specific to prebiotic activity; research focuses on changes in gut microbial composition or short-chain fatty acid levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prebiotic activity.